Bowel cancer screening less likely with low numeracy skills
the ONA take:
According to a new study published in the Journal of Health Psychology, those who have trouble understanding numbers may be less likely to undergo screening for bowel cancer, as well as being more likely to fear a negative result.
For the study, researchers asked people aged 45 to 59 to complete a questionnaire that evaluated their attitudes toward the bowel screening test and their numerical skills. For example, one question asked to identify whether 1 in 10, 1 in 100, or 1 in 1000 represents the greatest risk of developing a disease. About 46% of the 965 respondents got this question wrong.
Furthermore, respondents who were found to have lower numerical skills were more likely to believe that the test was disgusting or embarrassing, and more afraid of a negative result. These people also tended to understand less about the disease and were more likely ignore cancer information.
Specifically, respondents with low numerical skills were more likely to believe they did not need to be screened because they believed they were healthy and their physicians had not advised them to do so.
The findings of this study may help clinicians identify patients less likely to undergo a bowel cancer screening and to aid patients overcome barriers to prevent cancer or detect it early.
Those who have trouble understanding numbers may be less likely to undergo screening for bowel cancer.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|